BriaCell Therapeutics Corp. (BCT)
BriaCell Therapeutics Corp. is a diversified issuer with ~99.1% warrant dilution.
- Ticker
- BCT
- Exchange
- TSX
- Primary commodity
- diversified
- Sector
- mining
- Shares outstanding
- 7,250,487
Warrant overhang
15 active warrant series covering 7,183,242 shares (~99.1% potential dilution); nearest expiry 2026-06-07.
View warrant overhang tool →Recent news
All news →Profile assembled from Strikepoint Newssignal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. Informational only; verify against original filings before drawing conclusions.